MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) chemotherapy regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) chemotherapy regimen, covering 2019-08-21 to 2019-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Dose Dense MVAC for Muscle Invasive Bladder Cancer [Phase 2]